Colorectal cancer trials in Romania

In Romania 9 Also abroad 1930

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Where
Bucharest, Cluj-Napoca, Craiova, Floresti, Iași, Sibiu, Timișoara
Age
18 years and over
People
477 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00
Phase 3Taking people
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Where
Brasov, Bucharest, Cluj-Napoca, Craiova, Iași, Oradea
Age
18 years and over
People
700 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00
Phase 3Not yet taking people in Romania
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
Where
Bucharest, Craiova, Hunedoara
Age
18 years and over
People
450 worldwide
Run by
Genmab A/S
See details and how to join2026-525883-17-00 · EU 2026-525883-17-00
Phase 2/3Taking people
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Where
Bucharest, Cluj-Napoca, Craiova, Floresti, Iasi, Iași
Age
18 years and over
People
990 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00
No phaseTaking people
Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery
Where
Bucharest
Age
18 years and over
People
320
Run by
Bucharest Emergency Hospital
See details and how to joinNCT07881133
No phaseTaking people
Multicentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Methods
Where
Bucharest
Age
18 years and over
People
4,100 worldwide
Run by
Firalis SA
See details and how to joinNCT06515821
Phase 3Taking people
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Where
Bucharest, Cluj-Napoca, Craiova, Iași, Ploieşti, Timișoara
Age
18 years and over
People
450 worldwide
Run by
Amgen
See details and how to joinNCT06252649
Phase 3Taking people
Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
Where
Bucharest, Cluj-Napoca, Craiova, Jassi, Ploieşti, Timisoara
Age
18 years to 64 years
People
241 worldwide
Run by
Amgen Inc.
See details and how to join2022-502352-31-00 · EU 2022-502352-31-00
No phaseTaking people
Endoscopic Submucosal Dissection Registry
Where
Bucharest
Age
18 years to 100 years
People
200
Run by
Carol Davila University of Medicine and Pharmacy
See details and how to joinNCT06033976